AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2020
Feb 6, 2020
30237_dirs_2020-02-06_6f36b5ea-754a-41e0-9df7-86d1442e5443.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-02-04
Reporting Person: Seltz Judith C (Chief Human Resources Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-04 | Restricted Stock Unit | $ | A | 840 | Acquired | Common Stock (840) | Direct | |
| 2020-02-04 | Non-qualified Stock Options | $182.51 | A | 3600 | Acquired | 2030-02-03 | Common Stock (3600) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: The Restricted Stock Units vest in three equal annual installments beginning on February 4, 2021.
F3: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F4: The option vests in three equal annual installments beginning on the date reflected in this column.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 26
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Earnings Release
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Notice of Dividend Amount
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30